MCID: TYP007
MIFTS: 61

Typhoid Fever malady

Categories: Rare diseases, Infectious diseases

Aliases & Classifications for Typhoid Fever

About this section
Sources:
2CDC, 11Disease Ontology, 13DISEASES, 30ICD10, 31ICD10 via Orphanet, 32ICD9CM, 39MeSH, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS
See all MalaCards sources

Aliases & Descriptions for Typhoid Fever:

Name: Typhoid Fever 11 48 54 50 2 39 13 68
Typhoid 11 48 54 13
Typhoidal Salmonellosis 54
 
Typhoid Infection 11
Enteric Fever 48
Msh:d004239 11

Characteristics:

Orphanet epidemiological data:

54
typhoid fever:
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe),>1/1000 (South East Asia),1-5/10000 (Latin America),1-5/10000 (Africa),1-9/1000000 (North America),1-5/10000 (Oceania),1-9/1000000 (France); Age of onset: All ages; Age of death: adolescent,late childhood

Classifications:



External Ids:

Disease Ontology11 DOID:13258
ICD1030 A01.0, A01.00
ICD9CM32 002.0
MeSH39 D014435
NCIt45 C35089
Orphanet54 ORPHA99745
ICD10 via Orphanet31 A01.0

Summaries for Typhoid Fever

About this section
Disease Ontology:11 A primary bacterial infectious disease that is a communicable systemic illness, has material basis in Salmonella enterica subsp enterica serovar Typhi, which is transmitted by ingestion of food or water contaminated with the feces of an infected person. The infection has symptom fever, has symptom diarrhea, has symptom prostration, has symptom headache, has symptom splenomegaly, has symptom liver enlargement, has symptom eruption of rose-colored spots, and has symptom leukopenia.

MalaCards based summary: Typhoid Fever, also known as typhoid, is related to hemophagocytic lymphohistiocytosis and scarlet fever, and has symptoms including hallucinations, abdominal pain and migraine. An important gene associated with Typhoid Fever is SLC11A1 (Solute Carrier Family 11 Member 1), and among its related pathways are LDL Oxidation in Atherogenesis and IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types. The drug ciprofloxacin has been mentioned in the context of this disorder. Affiliated tissues include testes, liver and skin, and related mouse phenotypes are renal/urinary system and integument.

Wikipedia:71 Typhoid fever, also known simply as typhoid, is a bacterial infection due to Salmonella Typhi that... more...

Related Diseases for Typhoid Fever

About this section

Diseases related to Typhoid Fever via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 375)
idRelated DiseaseScoreTop Affiliating Genes
1hemophagocytic lymphohistiocytosis30.4IFNG, IL6, TNF
2scarlet fever30.3IL1B, IL6, TNF
3adult respiratory distress syndrome30.1CRP, IL6, TNF
4atrophic rhinitis29.7ALB, IL1B, IL6
5systemic lupus erythematosus28.0ALB, CRP, IFNG, IL6, LTA, TLR5
6malaria27.2ALB, CASP1, CRP, IFNG, IFNGR1, IL1B
7typhoidal tularemia12.0
8paratyphoid fever11.4
9diverticulitis of colon11.2
10inflammatory linear verrucous epidermal nevus10.6IFNG, IFNGR1
11thyroid malformation10.6IL1B, TNF
12autoimmune pancreatitis10.6IFNG, TNF
13hypospadias, hypertelorism, upper lid coloboma, and mixed-type hearing loss10.6IL1B, TNF
14aortic arch interruption10.6IL6, TNF
15scrub typhus10.6ALB, TNF
16cutaneous leishmaniasis10.6IL6, TNF
17pulmonary hypertension10.5IL1B, TNF
18bulbospinal polio10.5IFNG, TLR4
19hypospadias10.5IFNG, IFNGR1, TNF
20pasteurellosis10.5IFNG, IL6, TNF
21neurogenic bladder10.5TLR4, TNF
22lymphocytic colitis10.5IFNG, IL6, TNF
23renal cell carcinoma 410.5IFNG, IL6, TNF
24atrial tachyarrhythmia with short pr interval10.5IFNG, IFNGR1, SLC11A1
25graft-versus-host disease, protection against10.5IFNG, TNF
26mastocytosis cutaneous with short stature conductive hearing loss and microtia10.5IFNG, IL6, TNF
27leukostasis10.5IFNG, IL6, TNF
28dementia - subcortical10.5IFNG, IL6, TNF
29corneal deposit10.5IL1B, IL6
30baetz-greenwalt syndrome10.5IFNG, IL1B, TNF
31bile duct signet ring cell carcinoma10.5IFNG, IL6, TNF
32orbital periostitis10.5IFNG, IL6, TNF
33reproductive system disease10.5IFNG, IL6, TNF
34muscle cancer10.5ALB, IFNG
35heart leiomyosarcoma10.5IFNG, IL6, TNF
36tarsal tunnel syndrome10.5IL1B, IL6
37burn scar10.5IFNG, IL6, TNF
38binocular vision disease10.4IFNG, TLR4, TNF
39pseudoretinitis pigmentosa10.4IFNG, IL1B, TNF
40tricho odonto onycho dermal syndrome10.4IL6, TNF
41idiopathic interstitial pneumonia10.4IFNG, IL6, TNF
42geniculate herpes zoster10.4IFNG, IL6, TNF
43antigen-peptide-transporter 2 deficiency10.4IL6, TLR4, TNF
44kernicterus10.4IFNG, IL6, TNF
45blood group incompatibility10.4IFNG, IL6, TNF
46aneurysm of sinus of valsalva10.4CRP, IL6
47secondary lacrimal atrophy10.4IFNG, IL1B, TNF
48wissler's syndrome10.4IFNG, IL1B, TNF
49scrotum paget's disease10.4IL1B, IL6, TNF
50fibrous histiocytoma10.4ALB, IFNG, TNF

Graphical network of the top 20 diseases related to Typhoid Fever:



Diseases related to typhoid fever

Symptoms & Phenotypes for Typhoid Fever

About this section

Symptoms:

 11 (show all 8)
  • fever
  • diarrhea
  • prostration
  • headache
  • splenomegaly
  • liver enlargement
  • eruption of rose-colored spots
  • leukopenia

Human phenotypes related to Typhoid Fever:

 64 54 (show all 37)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 hallucinations64 hallmark (90%) HP:0000738
2 abdominal pain64 54 hallmark (90%) Very frequent (99-80%) HP:0002027
3 migraine64 hallmark (90%) HP:0002076
4 abnormality of the gastric mucosa64 hallmark (90%) HP:0004295
5 abnormality of temperature regulation64 hallmark (90%) HP:0004370
6 insomnia64 54 hallmark (90%) Very frequent (99-80%) HP:0100785
7 skin rash64 54 typical (50%) Frequent (79-30%) HP:0000988
8 hypermelanotic macule64 typical (50%) HP:0001034
9 hypertonia64 54 typical (50%) Frequent (79-30%) HP:0001276
10 hyperreflexia64 54 typical (50%) Frequent (79-30%) HP:0001347
11 splenomegaly64 54 typical (50%) Frequent (79-30%) HP:0001744
12 hepatomegaly64 54 typical (50%) Frequent (79-30%) HP:0002240
13 incoordination64 typical (50%) HP:0002311
14 arthralgia64 54 typical (50%) Frequent (79-30%) HP:0002829
15 myalgia64 54 typical (50%) Frequent (79-30%) HP:0003326
16 epistaxis64 54 occasional (7.5%) Occasional (29-5%) HP:0000421
17 tremor64 54 occasional (7.5%) Occasional (29-5%) HP:0001337
18 sudden cardiac death64 occasional (7.5%) HP:0001645
19 diarrhea64 54 occasional (7.5%) Occasional (29-5%) HP:0002014
20 constipation64 54 occasional (7.5%) Occasional (29-5%) HP:0002019
21 restrictive ventilatory defect64 occasional (7.5%) HP:0002091
22 gastrointestinal hemorrhage64 54 occasional (7.5%) Occasional (29-5%) HP:0002239
23 encephalitis64 54 occasional (7.5%) Occasional (29-5%) HP:0002383
24 reduced consciousness/confusion64 occasional (7.5%) HP:0004372
25 thrombophlebitis64 occasional (7.5%) HP:0004418
26 ataxia54 Frequent (79-30%)
27 lethargy54 Occasional (29-5%)
28 coma54 Occasional (29-5%)
29 cardiac arrest54 Occasional (29-5%)
30 fever54 Very frequent (99-80%)
31 headache54 Very frequent (99-80%)
32 venous thrombosis54 Occasional (29-5%)
33 interstitial pulmonary disease54 Occasional (29-5%)
34 arrhythmia54 Frequent (79-30%)
35 fatigue54 Very frequent (99-80%)
36 macule54 Frequent (79-30%)
37 cough54 Occasional (29-5%)

MGI Mouse Phenotypes related to Typhoid Fever according to GeneCards Suite gene sharing:

41 (show all 15)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.9ALB, CASP1, IFNG, IFNGR1, IL6, TLR4
2MP:00107718.8CASP1, IFNG, IFNGR1, IL1B, IL6, TLR4
3MP:00053848.3ALB, CASP1, IFNG, IFNGR1, IL6, OMP
4MP:00053868.3CFTR, IFNG, IFNGR1, IL6, LTA, OMP
5MP:00020068.1ALB, CASP1, IFNG, IFNGR1, IL1B, IL6
6MP:00053708.1ALB, CFTR, IFNG, IFNGR1, IL6, LTA
7MP:00036318.0CASP1, IFNG, IFNGR1, IL1B, IL6, LTA
8MP:00053797.8ALB, CASP1, CFTR, IFNG, IFNGR1, IL6
9MP:00053817.8ALB, CASP1, CFTR, IFNG, IFNGR1, IL6
10MP:00053887.7CFTR, IFNG, IL6, LTA, OMP, TLR4
11MP:00053857.6CASP1, CRP, IFNG, IFNGR1, IL1B, IL6
12MP:00053876.8CASP1, CFTR, CRP, IFNG, IFNGR1, IL1B
13MP:00107686.6ALB, CASP1, CFTR, IFNG, IFNGR1, IL1B
14MP:00053976.5CASP1, CFTR, IFNG, IFNGR1, IL1B, IL6
15MP:00053765.6ALB, CASP1, CFTR, CRP, IFNG, IFNGR1

Drugs & Therapeutics for Typhoid Fever

About this section

Drugs for Typhoid Fever (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 48)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CefiximeapprovedPhase 42179350-37-154362, 5362065
Synonyms:
(-)-Cefixim
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b
79350-37-1
7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
AB00513842
AC-4350
AC1NSFNI
BPBio1_000622
BRD-K71059170-001-02-5
BSPBio_000564
C06881
CEFIXIME
CFIX
CHEBI:472657
CHEBI:530642
CHEMBL1541
CID5362065
 
CL-284635
Cefixim
Cefixima
Cefixima [Spanish]
Cefixime (JP15/USP/INN)
Cefixime Anhydrous
Cefiximum
Cefiximum [Latin]
Céfixime
D00258
Denvar
FK-027
FR-17027
LS-187248
MLS002222332
MolPort-003-845-687
NCGC00179521-01
Necopen
Prestwick3_000462
SMR001307271
Suprax (TN)
Tricef
2
AzithromycinapprovedPhase 4, Phase 333383905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
3
CeftriaxoneapprovedPhase 411473384-59-55479530, 5361919
Synonyms:
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
104376-79-6
104376-79-6 (di-hydrochloride salt)
73384-59-5
74578-69-1 (di-hydrochloride salt, hemiheptahydrate)
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
AC-1592
AC1NUIFE
Biotrakson
C06683
C18H18N8O7S3
CEFTRIAXONE SODIUM
CHEBI:29007
CHEMBL161
CID5479530
CTRX
Cefatriaxone
Ceftriaxon
Ceftriaxona
Ceftriaxona [INN-Spanish]
 
Ceftriaxone (INN)
Ceftriaxone (TN)
Ceftriaxone [USAN:JAN]
Ceftriaxone intravenous
Ceftriaxone, Disodium Salt
Ceftriaxone, Disodium Salt, Hemiheptahydrate
Ceftriaxonum
Ceftriaxonum [INN-Latin]
Ceftriazone
D07659
DB01212
DRG-0071
EINECS 277-405-6
LS-150031
Longacef
Longaceph
MolPort-005-933-495
Ro 139904
Ro-13-9904
Ro13-9904
Rocefin
Rocephin
Rocephine
UNII-75J73V1629
ceftriaxone
4
Gatifloxacinapproved, investigationalPhase 433112811-59-35379
Synonyms:
(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
112811-59-3
160738-57-8
180200-66-2
AC-1944
AC1L1K82
AKOS004119932
AM 1155
AM-1155
AM-1155 (*Sesquihydrate*)
BB_SC-1123
BMS 206584-01
BMS-206584
BMS-206584-01
BRD-A74980173-001-02-8
BSPBio_002697
Bonoq
C07661
CG 5501
CG-5501
CHEBI:5280
CHEMBL31
CID5379
CPD000043336
D08011
DB01044
FT-0082686
GTFX
Gaity
Gatiflo
Gatiflo,Tequin and Zymar, Gatifloxacin
Gatifloxacin
Gatifloxacin & Gamma Interferon
Gatifloxacin (INN)
Gatifloxacin (TN)
Gatifloxacin [USAN:INN]
Gatifloxacin anhydrous
Gatifloxacine
Gatifloxacino
 
Gatifloxacinum
Gatilox
Gatiquin
Gatispan
HMS1922J15
HMS2090K10
HMS2093G06
I06-2286
I06-2287
KBio2_002442
KBio2_005010
KBio2_007578
KBio3_001917
KBioGR_001613
KBioSS_002448
Kinome_3137
LS-184402
MLS000040259
MLS000759493
MolPort-001-738-626
NCGC00095126-01
NCGC00095126-02
NCGC00178525-01
PD 135432
PD-135432
PD135432
S1340_Selleck
S1340_Sellekc
SAM001246715
SAM002589955
SMR000043336
SPBio_000353
SPECTRUM1504272
STK801620
Spectrum2_000487
Spectrum3_000999
Spectrum4_001127
Spectrum5_001468
Spectrum_001909
TL8001438
Tequin
Tequin in dextrose 5% in plastic container
Zymar
Zymaxid
Zymer
Zymer (TN)
5Antitubercular AgentsPhase 41272
6Anti-Bacterial AgentsPhase 4, Phase 310884
7Anti-Infective AgentsPhase 4, Phase 3, Phase 1, Phase 221402
8Antibiotics, AntitubercularPhase 46972
9Topoisomerase InhibitorsPhase 44945
10Nucleic Acid Synthesis InhibitorsPhase 44855
11FluoroquinolonesPhase 4388
12VaccinesPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 16428
13
Trimethoprimapproved, vet_approvedPhase 3173738-70-55578
Synonyms:
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
46984_FLUKA
46984_RIEDEL
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
738-70-5
92131_FLUKA
92131_SIGMA
AB00052118
AB1004879
AC-13572
AC1L1KNQ
AC1Q48DF
AI3-52594
AKOS001650069
ARONIS24118
AZT + TMP/SMX (mixture) combination
Abacin
Abaprim
Alcorim-F
Alprim
Anitrim
Antrima
Antrimox
Apo-Sulfatrim
BB_SC-2116
BIDD:GT0190
BPBio1_000215
BRD-K07208025-001-06-5
BRN 0625127
BSPBio_000195
BSPBio_002245
BW 56-72
BW 5672
BW-56-72
Bacdan
Bacidal
Bacide
Bacin
Bacta
Bacterial
Bacterial [Antibiotic]
Bacticel
Bactin
Bactoprim
Bactramin
Bactrim
Bactrim DS
Bactrim Pediatric
Baktar
Bencole
Bethaprim
Biosulten
Briscotrim
C01965
CAS-738-70-5
CCRIS 2410
CHEBI:45924
CHEMBL22
CID5578
CPD0-1581
CPD000035999
Chemotrim
Chemotrin
Cidal
Co-Trimoxizole
Co-trimoxazole
Colizole
Colizole DS
Comox
Conprim
Cotrim
Cotrim D.S.
Cotrimel
D00145
D014295
DB00440
Deprim
DivK1c_000589
Drylin
Duocide
EINECS 212-006-2
EU-0101271
Esbesul
Espectrin
Euctrim
Eusaprim
Exbesul
Fectrim
Fermagex
Fortrim
Futin
Gantaprim
Gantrim
HMS1568J17
HMS1921I03
HMS2090D14
HMS2092A10
HMS501N11
HSDB 6781
I06-0086
IDI1_000589
Idotrim
Ikaprim
Imexim
Instalac
Ipral
KBio1_000589
KBio2_000647
KBio2_003215
KBio2_005783
KBio3_001465
KBioGR_000863
KBioSS_000647
KSC-4-158
KUC103659N
Kepinol
Kombinax
LS-1627
Lagatrim
Lagatrim Forte
Laratrim
Lastrim
Lidaprim
Linaris
Lopac-T-7883
Lopac0_001271
MLS000079023
MLS001201740
MLS002303068
Methoprim
Metoprim
Microtrim
MolPort-001-826-685
Monoprim
Monotrim
Monotrimin
NCGC00016055-01
NCGC00016055-02
NCGC00016055-06
NCGC00016055-12
NCGC00024707-01
NCGC00024707-03
NCGC00024707-04
NCGC00024707-05
NCGC00024707-06
NCGC00024707-07
NCGC00024707-08
NIH 204
 
NIH 204 (VAN)
NINDS_000589
NSC 106568
NSC-106568
NSC106568
Nopil
Novotrimel
Omstat
Oprea1_495058
Oraprim
Pancidim
Polytrim
Prestwick0_000208
Prestwick1_000208
Prestwick2_000208
Prestwick3_000208
Prestwick_485
Priloprim
Primosept
Primsol
Proloprim
Proloprim (TN)
Protrin
Purbal
Resprim
Resprim Forte
Roubac
Roubal
SAM002264649
SMP2_000262
SMR000035999
SPBio_000874
SPBio_002116
SPECTRUM1500595
STK177322
Salvatrim
Septra
Septra DS
Septra Grape
Septrin
Septrin DS
Septrin Forte
Septrin S
Setprin
Sigaprim
Sinotrim
Smz-Tmp
Spectrum2_000937
Spectrum3_000643
Spectrum4_000372
Spectrum5_001559
Spectrum_000167
Stopan
Streptoplus
Sugaprim
Sulfamar
Sulfamethoprim
Sulfamethoprim-DS
Sulfamethoxazole & Trimethoprim
Sulfatrim
Sulfatrim Pediatric
Sulfatrim-DS
Sulfatrim-SS
Sulfotrim
Sulfoxaprim
Sulmeprim
Sulmeprim Pediatric
Sulprim
Sulthrim
Sultrex
Sumetrolim
Supracombin
Suprim
Syraprim
T 7883
T2286
T7883_SIGMA
TCMDC-125538
TL8005108
TMP/SMX (MIXTURE))
Teleprim
Thiocuran
Tiempe
Tmp-Ratiopharm
Tocris-0650
Toprim
Trigonyl
Trimanyl
Trimesulf
Trimeth/Sulfa
Trimethioprim
Trimethopim(TMP)
Trimethoprim
Trimethoprim & VRC3375
Trimethoprim (JAN/USP/INN)
Trimethoprim [USAN:BAN:INN:JAN]
Trimethoprime
Trimethoprime [INN-French]
Trimethoprimum
Trimethoprimum [INN-Latin]
Trimethopriom
Trimetoprim
Trimetoprim [DCIT]
Trimetoprim [Polish]
Trimetoprima
Trimetoprima [INN-Spanish]
Trimexazole
Trimexol
Trimez-IFSA
Trimezol
Trimogal
Trimono
Trimopan
Trimpex
Trimpex (TN)
Trimpex 200
Triméthoprime
Triprim
Trisul
Trisulcom
Trisulfam
Trisural
U-Prin
UNII-AN164J8Y0X
UPCMLD-DP132
UPCMLD-DP132:001
Unitrim
Uretrim
Uro-D S
Uro-Septra
Urobactrim
Uroplus
Uroplus DS
Uroplus SS
Utetrin
Velaten
WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1
WR 5949
Wellcoprim
Wellcoprin
Xeroprim
ZINC06627681
Zamboprim
component of Bactrim
component of Septra
nchembio.108-comp1
nchembio.215-comp11
nchembio.221-comp23
trimethoprim
14
SulfamethoxazoleapprovedPhase 3158723-46-65329
Synonyms:
129378-89-8
3-(Para-Aminophenylsulphonamido)-5-methylisoxazole
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(para-Aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-Benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide
4-Amino-N-[5-methyl-3- isoxazolyl]benzenesulfonamide
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
46850_RIEDEL
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
723-46-6
A047
AB00052099
AC-11118
AC1L1K42
AC1Q2J5R
AKOS000200952
ALBB-002089
ARONIS018156
Apo-Sulfamethoxazole
Azo Gantanol
Azo-Gantanol
Azo-gantanol
BAS 00836086
BB_SC-1251
BIDD:GT0731
BPBio1_000081
BRD-K28494619-001-05-0
BRN 0226453
BSPBio_000073
BSPBio_002028
Bactrim
Bactrimel
C07315
C10H11N3O3S
CAS-723-46-6
CCRIS 567
CHEBI:9332
CHEMBL443
CID5329
CPD000058223
D00447
D013420
DB01015
DivK1c_000649
EINECS 211-963-3
Gamazole
Gantanol
Gantanol (TN)
Gantanol (tn)
Gantanol-DS
HMS1568D15
HMS1921A21
HMS2092K03
HMS502A11
HMS561O18
HSDB 3186
I01-0154
IDI1_000649
InChI=1/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)
KBio1_000649
KBio2_001474
KBio2_004042
KBio2_006610
KBio3_001528
KBioGR_000749
KBioSS_001474
LS-1620
MLS000069732
MLS001055354
MLS001074165
MS 53
Maybridge1_007190
Metoxal
MolPort-000-145-787
N'-(5-Methyl-3-isoxazole)sulfanilamide
 
N'-(5-Methyl-3-isoxazolyl)-Sulfanilamide
N'-(5-Methyl-3-isoxazolyl)sulfanilamide
N'-(5-Methylisoxazol-3-yl)sulphanilamide
N(Sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide
N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
N1-(5-Methylisoxazol-3-yl)sulfanilamide
N1-(5-methyl-3-isoxazolyl)-Sulfanilamide
NCGC00016533-01
NCGC00016533-02
NCGC00021995-03
NCGC00021995-04
NCGC00021995-05
NINDS_000649
NSC 147832
NSC147832
N^1-(5-Methyl-3-isoxazolyl)-Sulfanilamide
Ndimethyl1-(5-methyl-3-isoxazolyl)-Sulfanilamide
Oprea1_114486
Oprea1_285680
Prestwick0_000177
Prestwick1_000177
Prestwick2_000177
Prestwick3_000177
Prestwick_453
Radonil
Ro 4-2130
Ro 6-2580/11
Ro-4-2130
S0361
S1915_Selleck
S7507_FLUKA
S7507_SIGMA
SAM002554930
SIM
SMR000058223
SMX
SPBio_000896
SPBio_001994
SPECTRUM1500550
STK007988
SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE)
Septran
Simsinomin
Sinomin
Solfametossazolo
Solfametossazolo [DCIT]
Spectrum2_000788
Spectrum3_000584
Spectrum4_000345
Spectrum5_000982
Spectrum_000994
Sulfamethalazole
Sulfamethoxazol
Sulfamethoxazole
Sulfamethoxazole (JP15/USP/INN)
Sulfamethoxazole [USAN:INN:JAN]
Sulfamethoxazole sodium
Sulfamethoxazole(USAN)
Sulfamethoxazolum
Sulfamethoxazolum [INN-Latin]
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfametoxazol [INN-Spanish]
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- (8CI)
Sulfisomezole
Sulpha-Methoxizole
Sulpha-methoxizole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulphamethylisoxazole
Sulphisomezole
TL8005058
TMP/SMX (MIXTURE))
Trib
UNII-JE42381TNV
Urobak
WLN: T5NOJ C1 EMSWR DZ
ZINC00089763
nchembio.221-comp24
sulfamethoxazole
15Antiprotozoal AgentsPhase 3, Phase 1, Phase 21986
16Antiparasitic AgentsPhase 3, Phase 1, Phase 22127
17
LactitolPhase 3, Phase 2332585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
18AntimalarialsPhase 31216
19Trimethoprim, Sulfamethoxazole Drug CombinationPhase 3164
20Renal AgentsPhase 3732
21
MetronidazoleapprovedPhase 1, Phase 2454443-48-14173
Synonyms:
1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(β-oxyethyl)-2-methyl-5-nitroimidazole
1-Hydroxyethyl-2-methyl-5-nitroimidazole
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
2-Methyl-5-nitro-1-imidazoleethanol
2-Methyl-5-nitroimidazole-1-ethanol
2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-methyl-5-nitroimidazole-1-ethanol
443-48-1
46461_FLUKA
46461_RIEDEL
69198-10-3 (mono-hydrochloride)
99616-64-5
AB00052046
AC-10556
AC1L1HKS
AC1Q2P2Z
AKOS000269646
APMN
ARONIS24285
Acromona
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAS 02983617
BAY-5360
BCBcMAP01_000184
BIDD:GT0107
BPBio1_000004
BRD-K52020312-001-05-2
BRN 0611683
BSPBio_000002
BSPBio_002031
Bayer 5360
Bexon
Bio-0694
CAS-443-48-1
CB-01-14 MMX
CCRIS 410
CHEBI:39845
CHEBI:6909
CHEMBL137
CID4173
CONT
CPD000058175
Caswell No. 579AA
Clont
D00409
DB00916
Danizol
Deflamon
Deflamon-wirkstoff
DivK1c_000007
EINECS 207-136-1
EPA Pesticide Chemical Code 120401
Efloran
Elyzol
Entizol
Eumin
FLAGYL I.V. RTU IN PLASTIC CONTAINER
Flagemona
Flagesol
Flagil
Flagyl
Flagyl (TN)
Flagyl 375
Flagyl Er
Flagyl I.V.
Flagyl I.V. RTU
Flegyl
Florazole
Fossyol
Giatricol
Ginefla vir
Gineflavir
HMS1568A04
HMS1920N19
HMS2051G07
HMS2090B19
HMS2091F14
HMS500A09
HMS547C19
HSDB 3129
I14-0667
IDI1_000007
IDR-90105
KBio1_000007
KBio2_001515
KBio2_004083
KBio2_006651
KBio3_001531
KBioGR_000559
KBioSS_001515
Klion
Klont
LS-1264
M0924
M1547_SIGMA
M3761_FLUKA
M3761_SIGMA
M9036_SIGMA
METRO I.V
METRONIDAZOLE USP
MLS000028590
MLS000758286
Maybridge1_001999
Meronidal
Methronidazole
Methyl-5-nitroimidazole-1-ethanol
 
Metric
Metric 21
Metro Cream
Metro Gel
Metro I.V.
Metro I.V. In Plastic Container
MetroCream
MetroGel
MetroGel-Vaginal
MetroLotion
Metrodzhil
Metrogel-vaginal (TN)
Metrogyl
Metrolag
Metrolyl
Metromidol
Metronidaz
Metronidazol
Metronidazol [INN-Spanish]
Metronidazole (JP15/USP/INN)
Metronidazole Benzoate
Metronidazole Monohydrochloride
Metronidazole Phosphoester
Metronidazole [USAN:INN:BAN:JAN]
Metronidazole in Plastic Container
Metronidazolo
Metronidazolo [DCIT]
Metronidazolum
Metronidazolum [INN-Latin]
Metrotop
Metrozine
Metryl
Mexibol
Mexibol 'silanes'
MolPort-000-141-892
MolPort-002-502-101
Monagyl
Monasin
NCGC00016446-01
NCGC00016446-02
NCGC00022059-03
NCGC00022059-04
NCGC00022059-05
NCIOpen2_000337
NIDA
NINDS_000007
NSC 50364
NSC 69587
NSC-50364
NSC50364
NSC69587
Nalox
Nidagel
Noritate
Noritate (TN)
Novonidazol
Orvagil
Prestwick0_000081
Prestwick1_000081
Prestwick2_000081
Prestwick3_000081
Prestwick_334
Protostat
RP 8823
RP-8823
Rathimed
Rosased
S1907_Selleck
SAM001247010
SBB041018
SC 10295
SMP1_000189
SMR000058175
SPBio_000666
SPBio_001941
SPECTRUM1500412
STK177359
Sanatrichom
Satric
Spectrum2_000883
Spectrum3_000506
Spectrum4_000060
Spectrum5_001289
Spectrum_001035
Takimetol
Trichazol
Trichex
Tricho cordes
Tricho-gynaedron
Trichocide
Trichomol
Trichomonacid 'pharmachim'
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
UNII-140QMO216E
Vagilen
Vagimid
Vandazole
Vertisal
WLN: T5N CNJ A2Q B1 ENW
WLN: T5N CNJA2Q B1 ENW
WLN: T6NTJ DQ ANU1- ET5N CNJ A1 BNW
Wagitran
ZERO/004064
ZINC00113442
Zadstat
Zidoval
giniflavir
metronidazole
neo-Tric
22
ZincapprovedPhase 1, Phase 222317440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
23
Albendazoleapproved, vet_approvedPhase 1, Phase 28054965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
24Zinc sulfateapprovedPhase 1, Phase 2667733-02-0
25
Formaldehydeapproved, vet_approvedPhase 28450-00-0712
Synonyms:
Aldeide formica
Fannoform
Formaldehyde
Formalin
Formalina
Formaline
Formalith
Formic aldehyde
Formol
 
Methaldehyde
Methanal
Methyl aldehyde
Methylene glycol
Methylene oxide
Oxomethane
Oxomethylene
Oxymethylene
Paraform
Paraformaldehyde
26
Vitamin Aapproved, nutraceutical, vet_approvedPhase 246811103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
27MicronutrientsPhase 1, Phase 25802
28SecnidazolePhase 1, Phase 25
29Heptavalent Pneumococcal Conjugate VaccinePhase 2454
30Liver ExtractsPhase 1, Phase 23868
31Trace ElementsPhase 1, Phase 25802
32Retinol palmitatePhase 2468
33AntibodiesPhase 26045
34ImmunoglobulinsPhase 26045
35Pharmaceutical SolutionsPhase 1, Phase 2, Early Phase 17793
36AnthelminticsPhase 1, Phase 2431
37AstringentsPhase 1, Phase 249
38Antimitotic AgentsPhase 1, Phase 25498
39Dermatologic AgentsPhase 1, Phase 25674
40Soy BeanNutraceuticalPhase 1, Phase 2535
41LecithinNutraceuticalPhase 1, Phase 270
42retinolNutraceuticalPhase 2468
43
LoperamideapprovedPhase 114353179-11-63955
Synonyms:
2-methoxyethyl1-methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
34552-83-5 (mono-hydrochloride)
4-(4-Chlorophenyl)-N,N-dimethyl-.alpha.,.alpha.-diphenyl-4-hydroxy-1-piperidinebutanamide
4-(4-Chlorophenyl)-N,N-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide
5-21-02-00379 (Beilstein Handbook Reference)
53179-11-6
AB00053697
AC1L1H38
AKOS000573892
Apo-Loperamide
BAS 01889668
BPBio1_000274
BRD-K61250553-001-02-9
BRD-K61250553-003-05-8
BRN 1558273
BSPBio_000248
BSPBio_001381
BSPBio_002769
Bio1_000082
Bio1_000571
Bio1_001060
Bio2_000101
Bio2_000581
C07080
C29H33ClN2O2
CAS-34552-83-5
CBiol_001796
CHEBI:162259
CHEBI:6532
CHEMBL841
CID3955
D08144
DB00836
Diamide (TN)
Diarr-Eze
DivK1c_000215
EINECS 258-416-5
HMS1791F03
HMS1989F03
HMS2089C13
IDI1_000215
IDI1_033851
Imodium A-D
Imodium A-D Caplets
Ioperamide
KBio1_000215
KBio2_000101
KBio2_000854
KBio2_002669
KBio2_003422
KBio2_005237
KBio2_005990
KBio3_000201
 
KBio3_000202
KBio3_001989
KBioGR_000101
KBioGR_001685
KBioSS_000101
KBioSS_000854
Kaopectate II
L000709
LS-114352
Lopac-L-4762
Lopac0_000708
Loperacap
Loperamid
Loperamida
Loperamida [INN-Spanish]
Loperamide (INN)
Loperamide Monohydrochloride
Loperamide [INN:BAN]
Loperamide hydrochloride
Loperamidum
Loperamidum [INN-Latin]
Lopéramide
Maalox Anti-Diarrheal
MolPort-001-969-016
NCGC00015608-01
NCGC00015608-08
NCGC00016828-01
NCGC00024818-01
NCGC00024818-02
NCGC00024818-03
NCGC00024818-04
NCGC00024818-05
NINDS_000215
Nu-Loperamide
Oprea1_109220
PMS-Loperamide
Pepto Diarrhea Control
Prestwick0_000144
Prestwick1_000144
Prestwick2_000144
Prestwick3_000144
R-18553
Rho-Loperamide
SPBio_001816
SPBio_002187
ST095179
Spectrum2_001738
Spectrum3_001015
Spectrum4_001143
Spectrum5_001374
Spectrum_000374
Tocris-0840
UNII-6X9OC3H4II
loperamide
nchembio.559-comp8
nchembio.79-comp7
44
PectinPhase 1349000-69-5441476
Synonyms:
(+)-Xylose
2,3,4,5-Tetrahydroxypentanal
D-Lyxose
DL-Xylose
L(+)-Xylose
 
L-Lyxose
Lyxose
Pectin
Pectin sugar
Pectinose
Pentose
Trobicin
45Gastrointestinal AgentsPhase 18109
46AntidiarrhealsPhase 1143
47BCG Vaccine103
48CantharidinEarly Phase 1956-25-7

Interventional clinical trials:

(show all 47)
idNameStatusNCT IDPhase
1Typhoid Fever: Combined vs. Single Antibiotic TherapyUnknown statusNCT02224040Phase 4
2Evaluation of the Vi Polysaccharide Vaccine Against Typhoid FeverCompletedNCT00125008Phase 4
3Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central VietnamCompletedNCT00131820Phase 4
4Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, ChinaCompletedNCT00131833Phase 4
5Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in ChildhoodCompletedNCT00125047Phase 4
6Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric FeverCompletedNCT01421693Phase 4
7Cross-reactive Immunity Elicited by Oral and Parenteral Typhoid VaccinesRecruitingNCT02121145Phase 4
8Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese SubjectsCompletedNCT01608815Phase 3
9Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & ImmunogenicityCompletedNCT00197249Phase 3
10A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsCompletedNCT01466387Phase 3
11Improving Rotavirus Vaccine Immune ResponseCompletedNCT01825109Phase 3
12Nepal Undifferentiated Febrile Illness TrialRecruitingNCT02773407Phase 3
13Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult SubjectsCompletedNCT00498654Phase 2
14Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in InfantsCompletedNCT00342628Phase 2
15Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy AdultsCompletedNCT00679172Phase 2
16TY800 Dose Escalation (Typhoid)CompletedNCT00269295Phase 1, Phase 2
17Studies of Immune Responses to Orally Administered Vaccines in Developing CountryCompletedNCT01019083Phase 1, Phase 2
18Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and InfantsCompletedNCT01229176Phase 2
19Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and InfantsCompletedNCT01437267Phase 2
20Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in AdultsCompletedNCT01438996Phase 2
21Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)CompletedNCT01193907Phase 2
22Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy SubjectsCompletedNCT00875524Phase 2
23Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma PatientCompletedNCT02338700Phase 1, Phase 2
24Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma PatientCompletedNCT02338804Phase 1, Phase 2
25Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma PatientCompletedNCT02338778Phase 1, Phase 2
26Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma PatientCompletedNCT02338752Phase 1, Phase 2
27Vaccines Against Salmonella TyphiRecruitingNCT02324751Phase 2
28Understanding Typhoid Disease After VaccinationActive, not recruitingNCT01405521Phase 2
29Vaccines and Dietary Oats in the Treatment of Ulcerative ColitisTerminatedNCT00751933Phase 2
30CVD 909 Vi Prime Boost StudyCompletedNCT00326443Phase 1
31Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate VaccineCompletedNCT00277147Phase 1
32Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)CompletedNCT01123941Phase 1
33Influence of Dietary Nitrate on Vascular Dysfunction and InflammationRecruitingNCT02715635Phase 1
34Safety and Immunogenicity of a Vi-DT Typhoid Conjugate VaccineNot yet recruitingNCT02645032Phase 1
35Investigating the Effects of Typhoid Vaccine on Sleep in Healthy VolunteersCompletedNCT02628054
36Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of AgeCompletedNCT00386789
37Role of BCG as Booster VaccinationCompletedNCT02175420
38Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder PatientsCompletedNCT01533285Early Phase 1
39Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)CompletedNCT01766830
40Global Genomic and Proteomic Profiling of African Children With Typhoid FeverRecruitingNCT02947295
41Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge StudyRecruitingNCT02192008
42Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer Who Received ChemotherapyRecruitingNCT02415387
43Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among TravelersRecruitingNCT02391909
44Causes of Fever in Bangladeshi PatientsRecruitingNCT02339259
45Understanding Paratyphoid InfectionActive, not recruitingNCT02100397
46Investigation of the Influence of Gender on Cardiovascular FunctionActive, not recruitingNCT01582321Early Phase 1
47Impact of Immune Challenge on Triple Network Connectivity in HumansNot yet recruitingNCT02653235

Search NIH Clinical Center for Typhoid Fever

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: typhoid fever

Genetic Tests for Typhoid Fever

About this section

Anatomical Context for Typhoid Fever

About this section

MalaCards organs/tissues related to Typhoid Fever:

36
Testes, Liver, Skin, Prostate, Bone, Bone marrow, Colon

Publications for Typhoid Fever

About this section

Articles related to Typhoid Fever:

(show top 50)    (show all 637)
idTitleAuthorsYear
1
A large and persistent outbreak of typhoid fever caused by consuming contaminated water and street-vended beverages: Kampala, Uganda, January - June 2015. (28056940)
2017
2
Typhoid fever in a Tertiary Hospital in Nigeria: Another look at the Widal agglutination test as a preferred option for diagnosis. (27397952)
2016
3
Typhoid Fever in South Africa in an Endemic HIV Setting. (27780232)
2016
4
A Comparative Evaluation of Different Diagnostic Modalities in the Diagnosis of Typhoid Fever Using a Composite Reference Standard: A Tertiary Hospital Based Study in Central India. (27891335)
2016
5
The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies. (26933028)
2016
6
Utilization of Healthcare in the Typhoid Fever Surveillance in Africa Program. (26933023)
2016
7
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever. (27217537)
2016
8
Efficacy of rapid antibody typhi point Elisa test in the diagnosis of typhoid fever when nested PCR was taken as gold standard. (27728395)
2016
9
Typhoid Fever, Below the Belt. (26894114)
2016
10
Third Generation Cephalosporins for Typhoid Fever. (27603449)
2016
11
Frosted Branch Angiitis in a Patient with Typhoid Fever. (28010144)
2016
12
A Qualitative Study Investigating Experiences, Perceptions, and Healthcare System Performance in Relation to the Surveillance of Typhoid Fever in Madagascar. (26933024)
2016
13
Typhoid fever: case report and literature review. (27392073)
2016
14
Typhoid toxin provides a window into typhoid fever and the biology of Salmonella Typhi. (27222578)
2016
15
The emergence and outbreak of multidrug-resistant typhoid fever in China. (27329848)
2016
16
Comparison of the Performance of the TPTest, Tubex, Typhidot and Widal Immunodiagnostic Assays and Blood Cultures in Detecting Patients with Typhoid Fever in Bangladesh, Including Using a Bayesian Latent Class Modeling Approach. (27058877)
2016
17
Challenges and Opportunities for Typhoid Fever Control: A Call for Coordinated Action. (26933019)
2016
18
Development of a live attenuated bivalent oral vaccine against Shigella sonnei shigellosis and typhoid fever. (27803169)
2016
19
The unrecognized burden of typhoid fever. (27797598)
2016
20
Low and declining attack rates of imported typhoid fever in the Netherlands 1997-2014, in spite of a restricted vaccination policy. (27905890)
2016
21
The Molecular and Spatial Epidemiology of Typhoid Fever in Rural Cambodia. (27331909)
2016
22
Evaluation of medicine retail outlets for sale of typhoid fever vaccine among adults in two urban and rural settings in western Kenya: a proof-of-concept study. (27688043)
2016
23
Clinical and Haematological Manifestations of Typhoid Fever in Children in Eastern Turkey. (26901611)
2016
24
Correction: Environmental Transmission of Typhoid Fever in an Urban Slum. (26727367)
2016
25
Notes from the Field: Typhoid Fever Outbreak Associated with an Asymptomatic Carrier at a Restaurant - Weld County, Colorado, 2015. (27310090)
2016
26
Severe thrombocytopenia in a child with typhoid fever: a case report. (27906062)
2016
27
Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans. (26928826)
2016
28
Immune Thrombocytopenic Purpura in Typhoid Fever. (27771690)
2016
29
Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies. (26822522)
2016
30
Pharyngeal Typhoid: A Rare Complication of Typhoid Fever. (27746454)
2016
31
Typhoid Fever in Children below 2A years of Age. (26817466)
2016
32
Detection of Salivary IgA Antibodies Against the HlyE Antigen as a Diagnosis of Typhoid Fever. (27504289)
2016
33
Identification of Five Novel Salmonella Typhi-Specific Genes as Markers for Diagnosis of Typhoid Fever Using Single-Gene Target PCR Assays. (27975062)
2016
34
GyrA ser83 and ParC trp106 Mutations in Salmonella enterica Serovar Typhi Isolated from Typhoid Fever Patients in Tertiary Care Hospital. (27630841)
2016
35
Serodiagnosis of Acute Typhoid Fever in Nigerian Pediatric Cases by Detection of Serum IgA and IgG against Hemolysin E and Lipopolysaccharide. (27215295)
2016
36
An Outbreak of Food-Borne Typhoid Fever Due to Salmonella enterica Serotype Typhi in Japan Reported for the First Time in 16 Years. (26621565)
2016
37
Diagnosis of imported Ugandan typhoid fever based on local outbreak information: A case report. (27297635)
2016
38
What Have We Learned From the Typhoid Fever Surveillance in Africa Program? (26933014)
2016
39
Modeling malaria and typhoid fever co-infection dynamics. (25865934)
2015
40
Diagnosis and Treatment of Typhoid Fever and Associated Prevailing Drug Resistance in Northern Ethiopia. (25931197)
2015
41
Genomic dissection of travel-associated extended-spectrum-beta-lactamase-producing Salmonella enterica serovar typhi isolates originating from the Philippines: a one-off occurrence or a threat to effective treatment of typhoid fever? (25428145)
2015
42
Typhoid Fever Complicated by Hemophagocytic Lymphohistiocytosis and Rhabdomyolysis. (26324725)
2015
43
Comparative Evaluation of Tubex TF (Inhibition Magnetic Binding Immunoassay) for Typhoid Fever in Endemic Area. (26676104)
2015
44
A case of typhoid Fever with hepatic granulomas and enteritis. (25699196)
2015
45
Environmental Transmission of Typhoid Fever in an Urban Slum. (26633656)
2015
46
Typhoid fever vaccination strategies. (25902360)
2015
47
Clinical features and outcome of typhoid fever and invasive non-typhoidal salmonellosis in a tertiary hospital in Belgium: analysis and review of the literature. (25819116)
2015
48
A review of typhoid fever transmission dynamic models and economic evaluations of vaccination. (25921288)
2015
49
Expression and Function of S100A8/A9 (Calprotectin) in Human Typhoid Fever and the Murine Salmonella Model. (25860480)
2015
50
The diagnostic accuracy of three rapid diagnostic tests for typhoid fever at Chittagong Medical College Hospital, Chittagong, Bangladesh. (26094960)
2015

Variations for Typhoid Fever

About this section

Expression for genes affiliated with Typhoid Fever

About this section
Search GEO for disease gene expression data for Typhoid Fever.

Pathways for genes affiliated with Typhoid Fever

About this section

Pathways related to Typhoid Fever according to GeneCards Suite gene sharing:

(show top 50)    (show all 57)
idSuper pathwaysScoreTop Affiliating Genes
19.8IL1B, TNF
29.8IL1B, IL6
39.6IFNG, IFNGR1, IL6
49.6IFNG, IFNGR1, IL6
59.6IFNG, IL6, TNF
69.6IFNG, IL6, TNF
79.5IFNG, IFNGR1, IL1B
89.5IL1B, IL6, TNF
99.5IL1B, IL6, TNF
109.5CASP1, IL1B
119.5IFNG, IL1B, IL6
129.3LTA, TLR4, TNF
139.3IFNG, IFNGR1, IL6, TLR4
149.3IFNG, IFNGR1, IL1B, TNF
159.2CASP1, IL1B, TNF
169.2IFNG, IL1B, IL6, TNF
179.2IFNG, IL1B, IL6, TNF
18
Show member pathways
9.2IFNG, IL1B, IL6, TNF
19
Show member pathways
9.2IFNG, IL1B, IL6, TNF
209.2IFNG, IL1B, IL6, TNF
219.2IFNG, IL1B, IL6, TNF
229.2IL1B, IL6, TLR4, TNF
239.2IFNG, IL1B, TLR4, TNF
24
Show member pathways
9.1IFNG, IFNGR1, LTA, TNF
259.0IL1B, IL6, LTA, TNF
269.0IL1B, IL6, LTA, TNF
279.0IFNG, IL1B, LTA, TNF
289.0IL1B, LTA, TLR4, TNF
29
Show member pathways
8.9IFNG, IFNGR1, IL1B, TLR4, TNF
30
Show member pathways
8.9CASP1, IL1B, IL6, TNF
31
Show member pathways
8.9IFNG, IL1B, IL6, TLR4, TLR5
328.9IFNG, IL1B, IL6, TLR4, TNF
338.9IFNG, IL1B, IL6, TLR4, TNF
348.9IFNG, IL1B, IL6, TLR4, TNF
358.9IFNG, IL1B, IL6, TLR4, TNF
368.8IL6, LTA, TLR4, TLR5, TNF
37
Show member pathways
8.7IFNG, IFNGR1, IL1B, LTA, TNF
388.7IFNG, IFNGR1, IL6, TLR4, TLR5, TNF
39
Show member pathways
8.7IFNG, IL1B, IL6, LTA, TNF
40
Show member pathways
8.6IFNG, IFNGR1, IL1B, TLR4, TLR5, TNF
41
Show member pathways
8.6CASP1, IFNG, IFNGR1, IL1B, IL6
42
Show member pathways
8.6IFNG, IFNGR1, IL1B, IL6, TLR4, TNF
438.6IFNG, IFNGR1, IL1B, IL6, TLR4, TNF
448.6CASP1, IL1B, IL6, TLR4, TNF
45
Show member pathways
8.4CASP1, LTA, TLR4, TLR5, TNF
46
Show member pathways
8.4IL1B, IL6, LTA, TLR4, TLR5, TNF
47
Show member pathways
8.3IFNG, IFNGR1, IL1B, IL6, TLR4, TLR5
488.3CASP1, IL1B, IL6, TLR4, TLR5, TNF
49
Show member pathways
8.1CASP1, IL1B, LTA, TLR4, TLR5, TNF
50
Show member pathways
8.0CASP1, IFNG, IFNGR1, IL1B, IL6, TLR4

GO Terms for genes affiliated with Typhoid Fever

About this section

Cellular components related to Typhoid Fever according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:000989710.0IFNG, IL6, TLR4, TNF
2extracellular regionGO:00055768.4ALB, CASP1, CRP, IFNG, IL1B, IL6
3extracellular spaceGO:00056157.8ALB, CRP, IFNG, IL1B, IL6, LTA

Biological processes related to Typhoid Fever according to GeneCards Suite gene sharing:

(show top 50)    (show all 59)
idNameGO IDScoreTop Affiliating Genes
1macrophage activationGO:004211610.7SLC11A1, TLR4
2epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.7IL6, TNF
3neutrophil apoptotic processGO:000178110.6IFNG, IL6
4chronic inflammatory response to antigenic stimulusGO:000243910.6IL1B, TNF
5positive regulation of interleukin-8 biosynthetic processGO:004541610.6TLR4, TNF
6negative regulation of lipid catabolic processGO:005099510.6IL1B, TNF
7negative regulation of interleukin-17 productionGO:003270010.6IFNG, TLR4
8positive regulation of fever generationGO:003162210.6IL1B, TNF
9positive regulation of heterotypic cell-cell adhesionGO:003411610.6IL1B, TNF
10regulation of interferon-gamma-mediated signaling pathwayGO:006033410.6IFNG, IFNGR1
11positive regulation of interleukin-12 biosynthetic processGO:004508410.6IFNG, TLR4
12positive regulation of MHC class II biosynthetic processGO:004534810.6IFNG, TLR4
13positive regulation of vitamin D biosynthetic processGO:006055710.5IFNG, TNF
14positive regulation of interleukin-6 biosynthetic processGO:004541010.5IFNG, IL1B
15regulation of cytokine secretionGO:005070710.5TLR4, TLR5
16regulation of establishment of endothelial barrierGO:190314010.5IL1B, TNF
17regulation of I-kappaB kinase/NF-kappaB signalingGO:004312210.5IL1B, TNF
18positive regulation of chronic inflammatory response to antigenic stimulusGO:000287610.4LTA, TNF
19positive regulation of humoral immune response mediated by circulating immunoglobulinGO:000292510.4LTA, TNF
20defense response to protozoanGO:004283210.4IFNG, IL6, SLC11A1
21sequestering of triglycerideGO:003073010.3IL1B, TNF
22positive regulation of phagocytosisGO:005076610.3IL1B, SLC11A1, TNF
23positive regulation of chemokine productionGO:003272210.3IL6, TLR4, TNF
24protein import into nucleus, translocationGO:000006010.3IFNG, SLC11A1, TNF
25positive regulation of calcidiol 1-monooxygenase activityGO:006055910.3IFNG, IL1B, TNF
26positive regulation of chemokine biosynthetic processGO:004508010.3IFNG, IL1B, TNF
27activation of MAPK activityGO:000018710.3IL1B, TLR4, TNF
28interleukin-1 beta productionGO:003261110.3CASP1, IL1B
29positive regulation of sequence-specific DNA binding transcription factor activityGO:005109110.2IL1B, IL6, TNF
30lipopolysaccharide-mediated signaling pathwayGO:003166310.2IL1B, TLR4, TNF
31positive regulation of membrane protein ectodomain proteolysisGO:005104410.2IFNG, IL1B, TNF
32positive regulation of JNK cascadeGO:004633010.2IL1B, TLR4, TNF
33positive regulation of NF-kappaB import into nucleusGO:004234610.2IL1B, TLR4, TNF
34positive regulation of T cell proliferationGO:004210210.2IFNG, IL1B, IL6
35negative regulation of lipid storageGO:001088810.2CRP, IL6, TNF
36response to virusGO:000961510.2IFNG, IFNGR1, TNF
37regulation of insulin secretionGO:005079610.1IFNG, IL1B, TNF
38negative regulation of growth of symbiont in hostGO:004413010.1IFNG, LTA, TNF
39defense response to Gram-negative bacteriumGO:005082910.1IL6, SLC11A1, TLR4, TLR5
40membrane hyperpolarizationGO:006008110.1CASP1, CFTR
41defense response to bacteriumGO:004274210.1IFNG, SLC11A1, TLR4, TNF
42positive regulation of interleukin-8 productionGO:00327579.9IL1B, TLR4, TLR5, TNF
43positive regulation of ERK1 and ERK2 cascadeGO:00703749.9IL1B, IL6, TLR4, TNF
44positive regulation of interleukin-6 productionGO:00327559.9IL1B, IL6, TLR4, TNF
45positive regulation of NF-kappaB transcription factor activityGO:00510929.9IL1B, IL6, TLR4, TNF
46humoral immune responseGO:00069599.8IFNG, IL6, LTA, TNF
47cellular response to lipopolysaccharideGO:00712229.7IFNG, IL6, TLR4, TLR5, TNF
48defense response to Gram-positive bacteriumGO:00508309.7CRP, IL6, LTA, TNF
49cellular response to mechanical stimulusGO:00712609.6CASP1, IL1B, TLR4, TLR5
50response to bacteriumGO:00096179.6CASP1, IL6, SLC11A1, TLR4

Molecular functions related to Typhoid Fever according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1interleukin-1 receptor bindingGO:00051499.8IL1B, TLR5
2cytokine activityGO:00051259.0IFNG, IL1B, IL6, LTA, TNF

Sources for Typhoid Fever

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet